Previous close | 2.9900 |
Open | 2.9900 |
Bid | 2.8300 x 200 |
Ask | 2.8700 x 300 |
Day's range | 2.8300 - 3.1100 |
52-week range | 2.6200 - 6.2500 |
Volume | |
Avg. volume | 374,380 |
Market cap | 138.421M |
Beta (5Y monthly) | -0.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.4400 |
Earnings date | 25 Mar 2024 - 29 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.07 |
On April 11, 2024, Ian Shakil, Chief Strategy Officer of Augmedix Inc (NASDAQ:AUGX), sold 92,787 shares of the company.
On April 8, 2024, Ian Shakil, Chief Strategy Officer of Augmedix Inc (NASDAQ:AUGX), sold 89,167 shares of the company.
SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today that it has integrated with Andor Health, an AI-first cloud-based communication and collaboration platform for virtual care. The alliance aims to harness the power of ambient documentation to transform the clinician-patien